The buoyancy in the sector is being driven by multiple factors, including regulatory shifts, policy support, and debt capital market activity in the city.
The UK pharmaceutical giant has announced a landmark $15bn China investment during the UK prime minister’s visit, marking its largest expansion yet to boost manufacturing, R&D and biotech collaboration.
The HSBC AI Markets platform, which provides proprietary natural language processing and advanced analytics, is helping clients from corporates to financial institutions to investors drive better, faster and more informed decision-making, explains HSBC’s Rahul Badhwar.
Hong Kong's finance chief discussed opportunities in the Northern Metropolis, developing AI, foreign tech firms entering the SAR, green finance, and China's evolving role in supply chains.
Coller Capital is a global secondaries firm with around $50bn in AUM and six Apac offices. EQT's CEO believes Coller's business can double in size in under four years; the PE giant is paying up to $3.7bn. In Japan, EQT has launched a bid for Mamezo.